Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals

Open access

Abstract

Ketamine improves motivation-related symptoms in depression but simultaneously elicits similar symptoms in healthy individuals, suggesting that it might have different effects in health and disease. This study examined whether ketamine affects the brain’s fronto-striatal system, which is known to drive motivational behavior. The study also assessed whether inflammatory mechanisms—which are known to influence neural and behavioral motivational processes—might underlie some of these changes. These questions were explored in the context of a double-blind, placebo-controlled, crossover trial of ketamine in 33 individuals with treatment-resistant major depressive disorder (TRD) and 25 healthy volunteers (HVs). Resting-state functional magnetic resonance imaging (rsfMRI) was acquired 2 days post-ketamine (final sample: TRD n = 27, HV n = 19) and post-placebo (final sample: TRD n = 25, HV n = 18) infusions and was used to probe fronto-striatal circuitry with striatal seed-based functional connectivity. Ketamine increased fronto-striatal functional connectivity in TRD participants toward levels observed in HVs while shifting the connectivity profile in HVs toward a state similar to TRD participants under placebo. Preliminary findings suggest that these effects were largely observed in the absence of inflammatory (C-reactive protein) changes and were associated with both acute and sustained improvements in symptoms in the TRD group. Ketamine thus normalized fronto-striatal connectivity in TRD participants but disrupted it in HVs independently of inflammatory processes. These findings highlight the potential importance of reward circuitry in ketamine’s mechanism of action, which may be particularly relevant for understanding ketamine-induced shifts in motivational symptoms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-020-00878-1

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Group differences in the effects of ketamine on functional connectivity across four striatal seeds. Ketamine differentially altered functional connectivity between the groups, as reflected in VS-left dlPFC (a), DC-right vlPFC (b), DCP-pgACC (c), and VRP-left/right OFC (d) coupling. This was identified using group-by-treatment F–tests at a family-wise error (FWE) cluster-corrected threshold level of p < 0.05. Boxplots with individual data points and distributions [75] show that functional connectivity was increased in individuals with treatment-resistant depresssion (TRD) but reduced in healthy volunteers (HVs) post-ketamine relative to placebo (a–d). Resting-state functional magnetic resonance imagining scans (rsfMRI) were acquired 2 days after each infusion. VS ventral striatum; DC dorsal caudate; DCP dorsal caudal putamen; VRP ventral rostral putamen; dlPFC dorsolateral prefrontal cortex; vlPFC ventrolateral prefrontal cortex; pgACC perigenual anterior cingulate cortex; OFC orbitofrontal cortex; L left; R right; FWE family–wise error.
Fig. 1 Group differences in the effects of ketamine on functional connectivity across four striatal seeds. Ketamine differentially altered functional connectivity between the groups, as reflected in VS-left dlPFC (a), DC-right vlPFC (b), DCP-pgACC (c), and VRP-left/right OFC (d) coupling. This was identified using group-by-treatment F–tests at a family-wise error (FWE) cluster-corrected threshold level of p < 0.05. Boxplots with individual data points and distributions [75] show that functional connectivity was increased in individuals with treatment-resistant depresssion (TRD) but reduced in healthy volunteers (HVs) post-ketamine relative to placebo (a–d). Resting-state functional magnetic resonance imagining scans (rsfMRI) were acquired 2 days after each infusion. VS ventral striatum; DC dorsal caudate; DCP dorsal caudal putamen; VRP ventral rostral putamen; dlPFC dorsolateral prefrontal cortex; vlPFC ventrolateral prefrontal cortex; pgACC perigenual anterior cingulate cortex; OFC orbitofrontal cortex; L left; R right; FWE family–wise error.CC BY · PubMed Central
Fig. 2 Ketamine had no effect on functional connectivity (data acquired 2 days post infusion) between the striatum and primary visual cortex (V1). Individual data points, boxplots, and data distributions are plotted for ventral striatum (VS)-V1 (a), dorsal caudate (DC)-V1 (b), dorsal caudal putamen (DCP)-V1 (c), and ventral rostral putamen (VRP)-V1 (d) functional connectivity post-ketamine and post-placebo for healthy volunteers (HVs) and individuals with treatment-resistant depression (TRD).
Fig. 2 Ketamine had no effect on functional connectivity (data acquired 2 days post infusion) between the striatum and primary visual cortex (V1). Individual data points, boxplots, and data distributions are plotted for ventral striatum (VS)-V1 (a), dorsal caudate (DC)-V1 (b), dorsal caudal putamen (DCP)-V1 (c), and ventral rostral putamen (VRP)-V1 (d) functional connectivity post-ketamine and post-placebo for healthy volunteers (HVs) and individuals with treatment-resistant depression (TRD).CC BY · PubMed Central
Fig. 3 Association between post-ketamine changes in inflammation and functional connectivity. The relationship between changes in ketamine and peripheral inflammation (measured by C-reactive protein (CRP) 1 day post–infusion) with changes in functional connectivity (measured 2 days post–infusion) between the ventral rostral putamen (VRP) and right orbitofrontal cortex (OFC). Data are plotted separately for healthy volunteers (HVs; p = 0.007) and individuals with treatment-resistant depression (TRD; p = 0.77). Δ ketamine minus placebo.
Fig. 3 Association between post-ketamine changes in inflammation and functional connectivity. The relationship between changes in ketamine and peripheral inflammation (measured by C-reactive protein (CRP) 1 day post–infusion) with changes in functional connectivity (measured 2 days post–infusion) between the ventral rostral putamen (VRP) and right orbitofrontal cortex (OFC). Data are plotted separately for healthy volunteers (HVs; p = 0.007) and individuals with treatment-resistant depression (TRD; p = 0.77). Δ ketamine minus placebo.CC BY · PubMed Central
Fig. 4 Association between post-ketamine changes in anhedonia and functional connectivity. Relationship between post-ketamine, compared with post-placebo, increases in fronto-striatal functional connectivity and improvements (negative numbers indicate post-ketamine improvements compared with post-placebo) in anhedonia symptoms on the day of the resting-state functional magnetic resonance imaging (rsfMRI) scan (2 days post infusion; a), and 10 days post infusion (b–d) in individuals with treatment-resistant depression (TRD). Shaded area represents estimated 95% confidence interval. SHAPS Snaith–Hamilton Pleasure Scale; DC dorsal caudate; vlPFC ventrolateral prefrontal cortex; DCP dorsal caudal putamen; pgACC perigenual anterior cingulate cortex; VRP ventral rostral putamen; OFC orbitofrontal cortex; Δ ketamine minus placebo.
Fig. 4 Association between post-ketamine changes in anhedonia and functional connectivity. Relationship between post-ketamine, compared with post-placebo, increases in fronto-striatal functional connectivity and improvements (negative numbers indicate post-ketamine improvements compared with post-placebo) in anhedonia symptoms on the day of the resting-state functional magnetic resonance imaging (rsfMRI) scan (2 days post infusion; a), and 10 days post infusion (b–d) in individuals with treatment-resistant depression (TRD). Shaded area represents estimated 95% confidence interval. SHAPS Snaith–Hamilton Pleasure Scale; DC dorsal caudate; vlPFC ventrolateral prefrontal cortex; DCP dorsal caudal putamen; pgACC perigenual anterior cingulate cortex; VRP ventral rostral putamen; OFC orbitofrontal cortex; Δ ketamine minus placebo.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

See all 112

Metadata

Authors
Mkrtchian, A., Evans, J. W., Kraus, C., Yuan, P., Kadriu, B., Nugent, A. C., Roiser, J. P., & Zarate, C. A.
Affiliations
  • National Institutes of Health (US)
  • University College London (GB)
Corresponding author
Mkrtchian, Anahit
Venue
Molecular Psychiatry
Published
2020-09-14
Volume
26
Issue
7
Pages
3292-3301
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W3086459126
Cited by
110
References
75
Citations by year
2026: 14 · 2025: 18 · 2024: 17 · 2023: 29 · 2022: 19 · 2021: 13
FWCI
9.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (ZIAMH002857)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
Keywords
ketamine, frontostriatal circuits, functional connectivity, striatum, motivation, reward systems, inflammation, C-reactive protein, placebo response
MeSH terms
Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Double-Blind Method, Humans, Ketamine, Magnetic Resonance Imaging, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals. https://app.cochat.ai/papers/10.1038/s41380-020-00878-1
The paper
Mkrtchian, A., Evans, J. W., Kraus, C., Yuan, P., Kadriu, B., Nugent, A. C., Roiser, J. P., & Zarate, C. A. (2021). Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals. Molecular Psychiatry. https://doi.org/10.1038/s41380-020-00878-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.